A clinical study of RC48-ADC combined with PD-1 inhibitor in bladder preservation therapy for muscle-invasive bladder cancer (MIBC)—based on real-world data analysis
International Urology and Nephrology · 14.05.2025 · 57 (12) · 3993-4001
DOI: 10.1007/s11255-025-04567-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urology and Nephrology, online erschienen am 14.05.2025. Verfasst von Shaolong Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Gansu Province Clinical Research Center for urinary system disease, The Second Hospital & Clinical Medical School, Lanzhou Uni…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Urinary Bladder, Immune Checkpoint Inhibitors, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Department of Science and Technology of Gansu Province, Basic research of science and technology innovation application - surface project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Gansu Province Clinical Research Center for urinary system disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- Department of Urology, Gansu Province Clinical Research Center for urinary system disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. dingh08@126.com.
Förderung
- Department of Science and Technology of Gansu Province
- Basic research of science and technology innovation application - surface project
Zitieren
APA
Zhang, S., Chen, C., Mo, C., Fan, N., Ning, Z., Wang, Z., & Ding, H. (2025). A clinical study of RC48-ADC combined with PD-1 inhibitor in bladder preservation therapy for muscle-invasive bladder cancer (MIBC)—based on real-world data analysis. International Urology and Nephrology, 57(12), 3993-4001. https://doi.org/10.1007/s11255-025-04567-2
Vancouver
Zhang S, Chen C, Mo C, Fan N, Ning Z, Wang Z, et al. A clinical study of RC48-ADC combined with PD-1 inhibitor in bladder preservation therapy for muscle-invasive bladder cancer (MIBC)—based on real-world data analysis. International Urology and Nephrology. 2025;57(12):3993-4001. doi:10.1007/s11255-025-04567-2
BibTeX
@article{Zhang2025,
author = {Zhang, Shaolong and Chen, Chuanjian and Mo, Chunhao and Fan, Ning and Ning, Zhongyun and Wang, Zhiping and Ding, Hui},
title = {A clinical study of RC48-ADC combined with PD-1 inhibitor in bladder preservation therapy for muscle-invasive bladder cancer (MIBC)—based on real-world data analysis},
journal = {International Urology and Nephrology},
year = {2025},
volume = {57},
number = {12},
pages = {3993--4001},
doi = {10.1007/s11255-025-04567-2}
}
EUVIMED